Products

ME-APDS™
MagenTeq Eye
Gastroenterology AI
Magentiq Eye's ME-APDS™ (MAGENTIQ-COLO™) is an FDA-cleared AI-aided colonoscopy system that provides real-time polyp detection to enhance diagnostic accuracy and improve patient outcomes in gastroenterology.

See all 1 product →

About MagenTeq Eye

MagenTeq Eye is a healthcare AI company specializing in advanced AI-powered colonoscopy solutions to enhance diagnostic capabilities for colorectal cancer. Their flagship product, MAGENTIQ-COLO™, leverages artificial intelligence and machine learning to improve adenoma detection rates during colonoscopy procedures. This technology aims to address the significant public health issue of colorectal cancer by providing real-time polyp analysis, including size and type estimation, and generating advanced AI-powered reports.

For physicians, MAGENTIQ-COLO™ offers a tool designed to improve clinical outcomes by increasing adenoma detection rates and reducing adenoma miss rates. The system has undergone extensive validation through studies involving over 950 patients across 10 countries. The company’s focus extends beyond colonoscopy, with ongoing clinical trials for diagnostic tools targeting other gastrointestinal conditions such as ulcerative colitis, early dysplasia in Barrett’s esophagus, and gastric intestinal metaplasia, as well as developing automated quality indicators for GI procedures.

MagenTeq Eye’s technology is FDA- and CE-approved, indicating its compliance with stringent regulatory standards for medical devices. The company aims to expand its commercial operations in the U.S. and Europe, making its advanced diagnostic tools accessible to more physicians and patients globally. Their revenue model primarily involves B2B sales to high-performing gastroenterology clinics and hospitals, with a focus on providing a fast return on investment through enhanced procedural efficiency and patient outcomes.

Focus Areas

AI-aided colonoscopy polyp detection computer-aided diagnosis (CADx) computer-aided quality indicator measurements (CAQ) gastrointestinal endoscopy deep learning computer vision video analysis diagnostic tools for ulcerative colitis Barrett's esophagus gastric intestinal metaplasia

Business Intelligence

TechnologyDeep machine learning, computer vision, video analysis, cloud-native (implied by AI-powered software and data processing)

What Physicians Need to Know

AI-Aided Polyp Detection
MagenTeq Eye's MAGENTIQ-COLO™ platform utilizes AI to analyze real-time video output from colonoscopies, highlighting adenoma lesions to assist physicians in detection. This system has demonstrated a 7% absolute and 37% relative increase in adenomas detected per colonoscopy, and a 17% absolute and 47% relative decrease in the adenoma miss rate compared to conventional colonoscopy. The device boasts a 99.6% polyp-wise sensitivity and 98% specificity. It also aids in real-time polyp size estimation and characterization, which is crucial for post-polypectomy surveillance intervals.
Computer-Aided Diagnosis (CADx)
The MAGENTIQ-COLO™ system integrates CADx capabilities to enhance diagnostic performance. This includes real-time polyp size estimation and characterization, which helps in classifying polyps as diminutive (≤5mm) or non-diminutive (>5mm). This is particularly valuable as non-expert endoscopists often struggle to meet diagnostic thresholds using standard visual inspection for diminutive polyps.
Computer-Aided Quality Indicator Measurements (CAQ)
MagenTeq Eye's platform incorporates CAQ capabilities to support procedural quality metrics and enable structured reporting in colonoscopy. CAQ systems objectively evaluate procedural metrics and provide real-time feedback, improving traditional quality indicators such as withdrawal time, bowel preparation scores, and cecal intubation rates. Emerging metrics like effective withdrawal time, fold examination quality, and withdrawal speed also offer novel, quantifiable insights. This can lead to increased mucosal exposure during colonoscopy and promote more careful visualization.
Gastrointestinal Endoscopy, Deep Learning, and Computer Vision
MagenTeq Eye specializes in AI-powered decision support for gastrointestinal endoscopy, leveraging deep learning and computer vision for video analysis. This technology analyzes video output from the colonoscope in real-time to identify and highlight lesions. Deep learning, particularly Convolutional Neural Networks (CNNs), has shown significant potential in gastrointestinal endoscopy for tasks like polyp detection and tumor classification.
Diagnostic Tools for Specific Conditions
While the primary focus is on colonoscopy, the underlying AI and image analysis technologies can be applied to other gastrointestinal conditions. Deep learning is revolutionizing the early detection and treatment of esophageal cancer and is proving to be a valuable screening tool. AI can assist in the detection of precancerous lesions in upper gastrointestinal endoscopy, such as Barrett's esophagus and early-stage gastric cancer. Barrett's esophagus involves changes in the esophageal lining, and its diagnosis often relies on endoscopic examination and biopsies. Gastric intestinal metaplasia is also a condition where AI-aided image analysis could be beneficial.
Physician Tip

For physicians, MagenTeq Eye's MAGENTIQ-COLO™ system offers a significant advancement in colonoscopy by providing real-time AI-powered assistance for polyp detection and characterization, leading to increased adenoma detection rates and reduced miss rates. This can enhance diagnostic confidence and consistency, particularly for diminutive polyps where visual inspection alone can be challenging. The integrated CAQ features provide objective feedback on procedural quality, helping to standardize and improve colonoscopy performance. The system's FDA clearance and CE mark for certain features, with additional CE-marked CADx and CAQ capabilities in Europe, indicate its clinical validation and regulatory compliance. This technology can ultimately contribute to earlier detection of colorectal cancer and improved patient outcomes.

MagenTeq Eye's MAGENTIQ-COLO™ platform is designed to integrate seamlessly into clinical practice, collaborating with trusted endoscopy platforms like those from PENTAX Medical. This integration allows for the deployment of their AI solution across various markets, expanding access to AI-assisted colonoscopy. The system analyzes real-time video output from existing colonoscopes, suggesting compatibility with current endoscopic equipment. The focus on real-time analysis and decision support indicates an integration designed to augment the physician's workflow during the procedure.

Products by MagenTeq Eye

1 product in the directory

ME-APDS™
MagenTeq Eye
Gastroenterology AI
Magentiq Eye's ME-APDS™ (MAGENTIQ-COLO™) is an FDA-cleared AI-aided colonoscopy system that provides real-time polyp detection to enhance diagnostic accuracy and improve patient outcomes in gastroenterology.

What the Web Says

It seems there is no company specifically named "MagenTeq Eye" with readily available reviews on the requested platforms (G2, Glassdoor, Capterra, Reddit, or healthcare IT review sites). The search results primarily show reviews for various eye care products (creams, serums, smart glasses, dart scoring systems) and unrelated companies with "Eye" in their name, such as "My Perfect Eyes" cosmetics, "Manhattan Eye" or "Massachusetts Eye and Ear" hospitals, and "Magruder Eye Institute." There are also some general discussions on Reddit about eye creams and their effectiveness. Therefore, a comprehensive review of "MagenTeq Eye" as a company or its products cannot be provided based on the current search.

Overall: Mixed

Limitations

No significant limitations found in public reviews. Consider checking vendor documentation or requesting a demo for a thorough evaluation.

Last updated: 2026-10-27

Videos

News, demos, and interviews about MagenTeq Eye.

Loading videos...

Videos load interactively. If none appear, search YouTube for MagenTeq Eye →

View all on YouTube

Press & Coverage

PRNewswire
PENTAX Medical Expands Partnership with MAGENTIQ EYE to Advance AI-Enabled Endoscopy Globally
PENTAX Medical expanded its partnership with MAGENTIQ EYE to include EMEA, JAPAC, and LATAM, integrating MAGENTIQ-COLO™ into PENTAX Medical's video processors to advance AI-enabled endoscopy worldwide.
2026-08
PENTAX Medical
PENTAX Medical and MAGENTIQ EYE Expand Global Partnership to Advance AI-Enabled Endoscopy
This expanded agreement between PENTAX Medical and MAGENTIQ EYE aims to bring clinically validated AI capabilities to more physicians globally, reinforcing their commitment to high-quality colonoscopy.
2026-08
PRNewswire
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
MagenTeq Eye completed its Series A funding round led by aMoon, with participation from other investors, to accelerate commercialization of its FDA- and CE-approved AI colonoscopy software MAGENTIQ-COLO™ and advance AI capabilities.
2025-07
MedPath
MAGENTIQ EYE Secures Series A Funding to Advance AI-Powered Colonoscopy Technology
MagenTeq Eye's Series A funding, led by aMoon, will support the commercialization of its FDA- and CE-approved AI colonoscopy software, MAGENTIQ-COLO™, and further development of its AI capabilities.
2025-07
HIT Consultant
MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology
MagenTeq Eye announced the successful completion of its Series A funding round, led by aMoon, to support the development and expansion of its diagnostic tools and drive commercial growth globally.
2025-08
Pharmaphorum
FDA approves new AI-powered colonoscopy aid
The FDA cleared MagenTeq Eye's AI software, MAGENTIQ-COLO™, for improving the accuracy of colonoscopy diagnoses, following its CE Mark and Israel AMAR approval.
2023-08
BioSpace
MAGENTIQ-EYE LTD. Announces FDA Clearance for MAGENTIQ-COLO™ AI-Aided Colonoscopy Solution
MagenTeq Eye announced FDA 510(k) clearance for its MAGENTIQ-COLO™ AI-aided colonoscopy solution, which significantly increases the Adenoma Detection Rate.
2023-07
Startup Nation Central
MAGENTIQ EYE: Improving Colonoscopy through AI
MagenTeq Eye develops an AI-aided colonoscopy solution, MAGENTIQ-COLO, leveraging deep learning and image processing to increase adenoma detection rates and improve colonoscopy quality.
2024-04

Frequently Asked Questions

MagenTeq Eye's core product is MAGENTIQ-COLO™, an AI-aided colonoscopy solution. It uses deep learning and computer vision to enhance polyp detection and analysis during colonoscopies, aiming to improve adenoma detection rates and reduce miss rates. The system highlights suspicious areas in real-time on the video feed, assisting endoscopists in identifying lesions.
Beyond general polyp detection, MagenTeq Eye is developing diagnostic tools for specialized diseases in the lower and upper gastrointestinal tract. These include ulcerative colitis, early dysplasia in Barrett's esophagus, and gastric intestinal metaplasia.
MagenTeq Eye's MAGENTIQ-COLO™ system has received both FDA and CE approval, indicating compliance with regulatory standards. Clinical trials have demonstrated its effectiveness, showing a significant increase in adenoma detection rates and a reduction in adenoma miss rates compared to conventional colonoscopy. The CE-marked version also includes computer-aided quality (CAQ) features for objective documentation of high-quality colonoscopy, such as automated Boston Bowel Preparation Score assessment and AI-based cecum detection.
MagenTeq Eye plans to achieve commercial growth through direct sales and partnerships with industry leaders. They have expanded their partnership with PENTAX Medical to distribute and support the MAGENTIQ-COLO™ integrated AI solution across the United States, EMEA, JAPAC, and LATAM regions, aiming to advance access to AI-enabled endoscopy worldwide.
MagenTeq Eye completed a Series A funding round led by aMoon, Israel's largest HealthTech dedicated investment fund, with participation from other investors including Norgine Ventures BV, Nina Capital, Namarel Ventures SL, Nova Capital, and private investors. This funding supports the continued development and expansion of their diagnostic tools and commercial growth.

Related Companies

CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7] Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing […]

Cosmo Artificial Intelligence (Cosmo AI) is a life sciences company specializing in MedTech AI, dermatology, and gastroenterology. The company focuses on developing and manufacturing innovative, high-quality products and technologies, particularly those supported by AI and digital health, to enhance healthcare delivery. Cosmo AI’s mission is to empower patients, healthcare professionals, and partners by innovating at […]

Exact Sciences is a molecular diagnostics company dedicated to the early detection and prevention of cancer, as well as guiding treatment decisions. The company is best known for its non-invasive colorectal cancer screening test, Cologuard, which analyzes stool samples for DNA markers and occult hemoglobin to assess a patient’s risk of colorectal cancer. Cologuard was […]

Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]

Motus GI Holdings, Inc. is a medical technology company that develops innovative solutions for gastrointestinal procedures, primarily focusing on enhancing colonoscopy outcomes. Their flagship product, the Pure-Vu System, is a U.S. FDA-cleared and CE-marked medical device designed to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper GI endoscopy procedures. The […]

Ambu is a global MedTech company that has been innovating healthcare solutions for over 85 years, with a strong focus on single-use medical devices. The company’s mission is to improve patient care through practical innovation, patient safety, and workflow efficiency. Ambu is particularly recognized for its pioneering work in single-use endoscopy, offering a comprehensive portfolio […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.